Raelipskie Partnership’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Buy
16,952
+2,222
+15% +$337K 1.04% 24
2025
Q4
$2.11M Buy
14,730
+375
+3% +$55.3K 0.89% 28
2025
Q3
$2.21M Buy
14,355
+95
+0.7% +$14.8K 0.95% 26
2025
Q2
$2.27M Buy
14,260
+3,701
+35% +$604K 1.04% 23
2025
Q1
$1.8M Buy
10,559
+233
+2% +$39K 0.92% 27
2024
Q4
$1.73M Sell
10,326
-549
-5% -$93.5K 0.86% 29
2024
Q3
$1.88M Buy
10,875
+600
+6% +$102K 0.92% 26
2024
Q2
$1.69M Hold
10,275
0.9% 27
2024
Q1
$1.67M Sell
10,275
-1,504
-13% -$236K 0.95% 25
2023
Q4
$1.73M Buy
+11,779
New +$1.74M 1.05% 25

Other funds holding PG

Raelipskie Partnership's PG Position: Q1 2026 in Review

Raelipskie Partnership increased its Procter & Gamble (PG) stake by 15% in Q1 2026, buying an estimated $337K and bringing the position to 16,952 shares worth $2.45M. The position accounts for 1.04% of the portfolio, ranked #24.

Raelipskie Partnership first reported a position in PG in Q4 2023 and has held it in 10 quarters since. 3,990 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Raelipskie Partnership held 16,952 shares of Procter & Gamble worth $2.45M as of Q1 2026.
  • Raelipskie Partnership bought 2,222 Procter & Gamble shares in Q1 2026, an estimated $337K.
  • Procter & Gamble made up 1.04% of Raelipskie Partnership's portfolio in Q1 2026, its #24 holding.
  • Raelipskie Partnership first reported a position in Procter & Gamble in Q4 2023 and has held it in 10 quarters since.
  • 3,990 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.